Caracterização epidemiológica e fenotípica da variante c.9382C>T (p.Arg3128Ter) no gene BRCA2 identificada em onze famílias num hospital do Norte de Portugal

Detalhes bibliográficos
Autor(a) principal: Ana Catarina da Silva Hilário
Data de Publicação: 2020
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/128662
Resumo: Introduction: The BRCA2 c.9382C>T (p.Arg3128Ter) variant is classified as pathogenic and is described in GnomAD at a frequency of 0.0021%. From the total of families with BRCA2 variants identified at Centro Hospitalar Universitário de São João, this is the second most frequent. The aim of this study is to characterize 11 families carrying this variant in the BRCA2 gene, as to their geographical distribution and the phenotypic characteristics expressed in the carriers. Material and Methods: Descriptive observational study, based on the review of clinical processes of individuals carrying the BRCA2 c.9382C>T variant, identified in the Oncogenetic Clinic of Centro Hospitalar Universitário de São João. Results: Eleven portuguese families were identified with the BRCA2 c.9382C>T variant, from Barcelos (n=5), Madeira (n=3), Braga (n=2) and Vila do Conde (n=1). From the 31 mutation carriers, 48.4% developed cancer, most of them breast cancer (n=11). The mean age at the first diagnosis was 40.5 ± 7.1 years. The most frequent histological type was the invasive carcinoma of no special type (n=6). All invasive carcinomas expressed hormonal receptors (n=9). Discussion: We found a number of families carrying the BRCA2 c.9382C>T variant higher than expected, given its frequency worldwide. Most patients developed breast cancer with histopathological characteristics consistent with that described in the literature for cancer associated with BRCA2 gene mutation. Conclusion: The recurrence of this variant may be related to a founding effect of the mutation in Portugal. We suggest nine microsatellite markers for a future haplotyping of these families.
id RCAP_778782e9bc82fa3fb3e6814d3175db85
oai_identifier_str oai:repositorio-aberto.up.pt:10216/128662
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Caracterização epidemiológica e fenotípica da variante c.9382C>T (p.Arg3128Ter) no gene BRCA2 identificada em onze famílias num hospital do Norte de PortugalMedicina clínicaClinical medicineIntroduction: The BRCA2 c.9382C>T (p.Arg3128Ter) variant is classified as pathogenic and is described in GnomAD at a frequency of 0.0021%. From the total of families with BRCA2 variants identified at Centro Hospitalar Universitário de São João, this is the second most frequent. The aim of this study is to characterize 11 families carrying this variant in the BRCA2 gene, as to their geographical distribution and the phenotypic characteristics expressed in the carriers. Material and Methods: Descriptive observational study, based on the review of clinical processes of individuals carrying the BRCA2 c.9382C>T variant, identified in the Oncogenetic Clinic of Centro Hospitalar Universitário de São João. Results: Eleven portuguese families were identified with the BRCA2 c.9382C>T variant, from Barcelos (n=5), Madeira (n=3), Braga (n=2) and Vila do Conde (n=1). From the 31 mutation carriers, 48.4% developed cancer, most of them breast cancer (n=11). The mean age at the first diagnosis was 40.5 ± 7.1 years. The most frequent histological type was the invasive carcinoma of no special type (n=6). All invasive carcinomas expressed hormonal receptors (n=9). Discussion: We found a number of families carrying the BRCA2 c.9382C>T variant higher than expected, given its frequency worldwide. Most patients developed breast cancer with histopathological characteristics consistent with that described in the literature for cancer associated with BRCA2 gene mutation. Conclusion: The recurrence of this variant may be related to a founding effect of the mutation in Portugal. We suggest nine microsatellite markers for a future haplotyping of these families.2020-06-252020-06-25T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttps://hdl.handle.net/10216/128662TID:202612295porAna Catarina da Silva Hilárioinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T14:34:40Zoai:repositorio-aberto.up.pt:10216/128662Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:04:21.783183Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Caracterização epidemiológica e fenotípica da variante c.9382C>T (p.Arg3128Ter) no gene BRCA2 identificada em onze famílias num hospital do Norte de Portugal
title Caracterização epidemiológica e fenotípica da variante c.9382C>T (p.Arg3128Ter) no gene BRCA2 identificada em onze famílias num hospital do Norte de Portugal
spellingShingle Caracterização epidemiológica e fenotípica da variante c.9382C>T (p.Arg3128Ter) no gene BRCA2 identificada em onze famílias num hospital do Norte de Portugal
Ana Catarina da Silva Hilário
Medicina clínica
Clinical medicine
title_short Caracterização epidemiológica e fenotípica da variante c.9382C>T (p.Arg3128Ter) no gene BRCA2 identificada em onze famílias num hospital do Norte de Portugal
title_full Caracterização epidemiológica e fenotípica da variante c.9382C>T (p.Arg3128Ter) no gene BRCA2 identificada em onze famílias num hospital do Norte de Portugal
title_fullStr Caracterização epidemiológica e fenotípica da variante c.9382C>T (p.Arg3128Ter) no gene BRCA2 identificada em onze famílias num hospital do Norte de Portugal
title_full_unstemmed Caracterização epidemiológica e fenotípica da variante c.9382C>T (p.Arg3128Ter) no gene BRCA2 identificada em onze famílias num hospital do Norte de Portugal
title_sort Caracterização epidemiológica e fenotípica da variante c.9382C>T (p.Arg3128Ter) no gene BRCA2 identificada em onze famílias num hospital do Norte de Portugal
author Ana Catarina da Silva Hilário
author_facet Ana Catarina da Silva Hilário
author_role author
dc.contributor.author.fl_str_mv Ana Catarina da Silva Hilário
dc.subject.por.fl_str_mv Medicina clínica
Clinical medicine
topic Medicina clínica
Clinical medicine
description Introduction: The BRCA2 c.9382C>T (p.Arg3128Ter) variant is classified as pathogenic and is described in GnomAD at a frequency of 0.0021%. From the total of families with BRCA2 variants identified at Centro Hospitalar Universitário de São João, this is the second most frequent. The aim of this study is to characterize 11 families carrying this variant in the BRCA2 gene, as to their geographical distribution and the phenotypic characteristics expressed in the carriers. Material and Methods: Descriptive observational study, based on the review of clinical processes of individuals carrying the BRCA2 c.9382C>T variant, identified in the Oncogenetic Clinic of Centro Hospitalar Universitário de São João. Results: Eleven portuguese families were identified with the BRCA2 c.9382C>T variant, from Barcelos (n=5), Madeira (n=3), Braga (n=2) and Vila do Conde (n=1). From the 31 mutation carriers, 48.4% developed cancer, most of them breast cancer (n=11). The mean age at the first diagnosis was 40.5 ± 7.1 years. The most frequent histological type was the invasive carcinoma of no special type (n=6). All invasive carcinomas expressed hormonal receptors (n=9). Discussion: We found a number of families carrying the BRCA2 c.9382C>T variant higher than expected, given its frequency worldwide. Most patients developed breast cancer with histopathological characteristics consistent with that described in the literature for cancer associated with BRCA2 gene mutation. Conclusion: The recurrence of this variant may be related to a founding effect of the mutation in Portugal. We suggest nine microsatellite markers for a future haplotyping of these families.
publishDate 2020
dc.date.none.fl_str_mv 2020-06-25
2020-06-25T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/128662
TID:202612295
url https://hdl.handle.net/10216/128662
identifier_str_mv TID:202612295
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799135967869665280